| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Cardiovascular Division, Department of Medicine, Minneapolis 55455
2 Informatics Division, Cancer Center, Minneapolis 55455
3 Cardiothoracic Surgery, University of Minnesota, Minneapolis 55455
4 Fairview Medical Center, Minneapolis 55455
5 Mayo Clinic, Rochester, Minnesota 55905
Mechanical unloading of the heart with a left ventricular assist device (LVAD) significantly decreases mortality in patients with heart failure. Moreover, it provides a human model to define the critical regulatory genes governing myocardial remodeling in response to significant reductions in wall stress. Statistical analysis of a gene expression library of 19 paired human heart samples harvested at the time of LVAD implant and again at explant revealed a set of 22 genes that were downregulated and 85 genes that were upregulated in response to mechanical unloading with a false discovery rate of less than 1%. The analysis revealed a high percentage of genes involved in the regulation of vascular networks including neuropilin-1 (a VEGF receptor), FGF9, Sprouty1, stromal-derived factor 1, and endomucin. Taken together these findings suggest that mechanical unloading alters the regulation of vascular organization and migration in the heart. In addition to vascular signaling networks, GATA-4 binding protein, a critical mediator of myocyte hypertrophy, was significantly downregulated following mechanical unloading. In summary, these findings may have important implications for defining the role of mechanical stretch and load on autocrine/paracrine signals directing vascular organization in the failing human heart and the role of GATA-4 in orchestrating reverse myocardial remodeling. This unbiased gene discovery approach in paired human heart samples has the potential to provide critical clues to the next generation of therapeutic treatments aimed at heart failure.
microarray; GATA-4; stretch; SDF-1; unloading
This article has been cited by other articles:
|
|
 |
|
  T. A. Bullard, T. L. Protack, F. Aguilar, S. Bagwe, H. T. Massey, and B. C. Blaxall Identification of Nogo as a novel indicator of heart failure Physiol Genomics, January 17, 2008; 32(2): 182 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Cappola Molecular Remodeling in Human Heart Failure J. Am. Coll. Cardiol., January 15, 2008; 51(2): 137 - 138. [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Hall, E. J. Birks, S. Grindle, M. E. Cullen, P. J. Barton, J. E. Rider, S. Lee, S. Harwalker, A. Mariash, N. Adhikari, et al. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy Eur. Heart J., March 1, 2007; 28(5): 613 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Lowes, M. L. Baker, and B. C. Blaxall Gene expression profile of the recovering human heart Eur. Heart J., March 1, 2007; 28(5): 522 - 524. [Full Text] [PDF]
|
|
|
|
|
|
M. P. Donahue, D. A. Marchuk, and H. A. Rockman Redefining Heart Failure: The Utility of Genomics J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1289 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Kong, W. T. Pu, and P. J. Park A multivariate approach for integrating genome-wide expression data and biological knowledge Bioinformatics, October 1, 2006; 22(19): 2373 - 2380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bisping, S. Ikeda, S. W. Kong, O. Tarnavski, N. Bodyak, J. R. McMullen, S. Rajagopal, J. K. Son, Q. Ma, Z. Springer, et al. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure PNAS, September 26, 2006; 103(39): 14471 - 14476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Cullen, A. H.Y. Yuen, L. E. Felkin, R. T. Smolenski, J. L. Hall, S. Grindle, L. W. Miller, E. J. Birks, M. H. Yacoub, and P. J.R. Barton Myocardial Expression of the Arginine:Glycine Amidinotransferase Gene Is Elevated in Heart Failure and Normalized After Recovery: Potential Implications for Local Creatine Synthesis Circulation, July 4, 2006; 114(1_suppl): I-16 - I-20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dai, P. Wang, A. D. Boyd, G. Kostov, B. Athey, E. G. Jones, W. E. Bunney, R. M. Myers, T. P. Speed, H. Akil, et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data Nucleic Acids Res., November 10, 2005; 33(20): e175 - e175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. R. Barton, L. E. Felkin, E. J. Birks, M. E. Cullen, N. R. Banner, S. Grindle, J. L. Hall, L. W. Miller, and M. H. Yacoub Myocardial Insulin-Like Growth Factor-I Gene Expression During Recovery From Heart Failure After Combined Left Ventricular Assist Device and Clenbuterol Therapy Circulation, August 30, 2005; 112(9_suppl): I-46 - I-50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Birks, J. L. Hall, P. J.R. Barton, S. Grindle, N. Latif, J. P. Hardy, J. E. Rider, N. R. Banner, A. Khaghani, L. W. Miller, et al. Gene Profiling Changes in Cytoskeletal Proteins During Clinical Recovery After Left Ventricular-Assist Device Support Circulation, August 30, 2005; 112(9_suppl): I-57 - I-64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Kittleson, K. M. Minhas, R. A. Irizarry, S. Q. Ye, G. Edness, E. Breton, J. V. Conte, G. Tomaselli, J. G. N. Garcia, and J. M. Hare Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure Physiol Genomics, May 11, 2005; 21(3): 299 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Kittleson, S. Q. Ye, R. A. Irizarry, K. M. Minhas, G. Edness, J. V. Conte, G. Parmigiani, L. W. Miller, Y. Chen, J. L. Hall, et al. Identification of a Gene Expression Profile That Differentiates Between Ischemic and Nonischemic Cardiomyopathy Circulation, November 30, 2004; 110(22): 3444 - 3451. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
